These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1369359)
21. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Carrillo C; Wigdorovitz A; Trono K; Dus Santos MJ; Castañón S; Sadir AM; Ordas R; Escribano JM; Borca MV Viral Immunol; 2001; 14(1):49-57. PubMed ID: 11270596 [TBL] [Abstract][Full Text] [Related]
22. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Mayr GA; Chinsangaram J; Grubman MJ Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121 [TBL] [Abstract][Full Text] [Related]
23. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology. Brown F Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918 [No Abstract] [Full Text] [Related]
24. The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus. Boothroyd JC; Harris TJ; Rowlands DJ; Lowe PA Gene; 1982 Feb; 17(2):153-61. PubMed ID: 6282711 [TBL] [Abstract][Full Text] [Related]
25. Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Klump W; Marquardt O; Hofschneider PH Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3351-5. PubMed ID: 6328511 [TBL] [Abstract][Full Text] [Related]
26. Expression of an active foot-and-mouth disease virus RNA polymerase in Escherichia coli. Brindeiro RM; Soares MA; Pacheco AB; de-Pontes OH; de-Almeida DF; Tanuri A Braz J Med Biol Res; 1991; 24(4):359-63. PubMed ID: 1668400 [TBL] [Abstract][Full Text] [Related]
27. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Kit M; Kit S; Little SP; Di Marchi RD; Gale C Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936 [TBL] [Abstract][Full Text] [Related]
28. Enhanced production of pL-controlled recombinant proteins and plasmid stability in Escherichia coli RecA+ strains. Benito A; Vidal M; Villaverde A J Biotechnol; 1993 Jun; 29(3):299-306. PubMed ID: 7764065 [TBL] [Abstract][Full Text] [Related]
29. VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences. Piccone ME; Kaplan G; Giavedoni L; Domingo E; Palma EL J Virol; 1988 Apr; 62(4):1469-73. PubMed ID: 2831408 [TBL] [Abstract][Full Text] [Related]
30. Efficient use of lactose for the lac promoter-controlled overexpression of the main antigenic protein of the foot and mouth disease virus in Escherichia coli under fed-batch fermentation conditions. Neubauer P; Hofmann K FEMS Microbiol Rev; 1994 May; 14(1):99-102. PubMed ID: 8011364 [TBL] [Abstract][Full Text] [Related]
31. Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli. Braun H; Boller K; Löwer J; Bertling WM; Zimmer A Biotechnol Appl Biochem; 1999 Feb; 29 ( Pt 1)():31-43. PubMed ID: 9889083 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus. Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE Gene; 1986; 49(2):189-97. PubMed ID: 2436976 [TBL] [Abstract][Full Text] [Related]
33. Foot-and-mouth disease virus capsid proteins VP0, VP1 and VP3 synthesized by "in vitro" translation are the major components of 14S particles. Grigera P; Vasquez C; Palmenberg A Acta Virol; 1985 Dec; 29(6):449-54. PubMed ID: 2869654 [TBL] [Abstract][Full Text] [Related]
34. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli. Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522 [TBL] [Abstract][Full Text] [Related]
35. Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Boothroyd JC; Highfield PE; Cross GA; Rowlands DJ; Lowe PA; Brown F; Harris TJ Nature; 1981 Apr; 290(5809):800-2. PubMed ID: 6261157 [TBL] [Abstract][Full Text] [Related]
36. Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Carrillo C; Dopazo J; Moya A; Gonzalez M; Martínez MA; Saiz JC; Sobrino F Virus Res; 1990 Jan; 15(1):45-55. PubMed ID: 2156389 [TBL] [Abstract][Full Text] [Related]
37. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice. Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723 [TBL] [Abstract][Full Text] [Related]
38. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates). Tulasiram P; Suryanarayana V Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655 [TBL] [Abstract][Full Text] [Related]
39. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine. Huang H; Yang Z; Xu Q; Sheng Z; Xie Y; Yan W; You Y; Sun L; Zheng Z Viral Immunol; 1999; 12(1):1-8. PubMed ID: 10333237 [TBL] [Abstract][Full Text] [Related]
40. C-terminal region of VP1 of selected foot-and-mouth disease virus serotypes: expression in E. coli and affinity purification. Ratish G; Viswanathan S; Suryanarayana VV Acta Virol; 1999 Aug; 43(4):205-11. PubMed ID: 10749365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]